Cargando…
Correction to: Treatment of neovascular age-related macular degeneration: insights into drug-switch real-world from the Berlin Macular Registry
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198818/ https://www.ncbi.nlm.nih.gov/pubmed/36795164 http://dx.doi.org/10.1007/s00417-023-06011-6 |
| _version_ | 1785044812214304768 |
|---|---|
| author | Riemer, Tommes Berndt, Dominique Böker, Alexander Lehmann, Josefine Schrifl, Ulrike Rau, Saskia Rübsam, Anne Joussen, Antonia M. Zeitz, Oliver |
| author_facet | Riemer, Tommes Berndt, Dominique Böker, Alexander Lehmann, Josefine Schrifl, Ulrike Rau, Saskia Rübsam, Anne Joussen, Antonia M. Zeitz, Oliver |
| author_sort | Riemer, Tommes |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10198818 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101988182023-05-21 Correction to: Treatment of neovascular age-related macular degeneration: insights into drug-switch real-world from the Berlin Macular Registry Riemer, Tommes Berndt, Dominique Böker, Alexander Lehmann, Josefine Schrifl, Ulrike Rau, Saskia Rübsam, Anne Joussen, Antonia M. Zeitz, Oliver Graefes Arch Clin Exp Ophthalmol Correction Springer Berlin Heidelberg 2023-02-16 2023 /pmc/articles/PMC10198818/ /pubmed/36795164 http://dx.doi.org/10.1007/s00417-023-06011-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Riemer, Tommes Berndt, Dominique Böker, Alexander Lehmann, Josefine Schrifl, Ulrike Rau, Saskia Rübsam, Anne Joussen, Antonia M. Zeitz, Oliver Correction to: Treatment of neovascular age-related macular degeneration: insights into drug-switch real-world from the Berlin Macular Registry |
| title | Correction to: Treatment of neovascular age-related macular degeneration: insights into drug-switch real-world from the Berlin Macular Registry |
| title_full | Correction to: Treatment of neovascular age-related macular degeneration: insights into drug-switch real-world from the Berlin Macular Registry |
| title_fullStr | Correction to: Treatment of neovascular age-related macular degeneration: insights into drug-switch real-world from the Berlin Macular Registry |
| title_full_unstemmed | Correction to: Treatment of neovascular age-related macular degeneration: insights into drug-switch real-world from the Berlin Macular Registry |
| title_short | Correction to: Treatment of neovascular age-related macular degeneration: insights into drug-switch real-world from the Berlin Macular Registry |
| title_sort | correction to: treatment of neovascular age-related macular degeneration: insights into drug-switch real-world from the berlin macular registry |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198818/ https://www.ncbi.nlm.nih.gov/pubmed/36795164 http://dx.doi.org/10.1007/s00417-023-06011-6 |
| work_keys_str_mv | AT riemertommes correctiontotreatmentofneovascularagerelatedmaculardegenerationinsightsintodrugswitchrealworldfromtheberlinmacularregistry AT berndtdominique correctiontotreatmentofneovascularagerelatedmaculardegenerationinsightsintodrugswitchrealworldfromtheberlinmacularregistry AT bokeralexander correctiontotreatmentofneovascularagerelatedmaculardegenerationinsightsintodrugswitchrealworldfromtheberlinmacularregistry AT lehmannjosefine correctiontotreatmentofneovascularagerelatedmaculardegenerationinsightsintodrugswitchrealworldfromtheberlinmacularregistry AT schriflulrike correctiontotreatmentofneovascularagerelatedmaculardegenerationinsightsintodrugswitchrealworldfromtheberlinmacularregistry AT rausaskia correctiontotreatmentofneovascularagerelatedmaculardegenerationinsightsintodrugswitchrealworldfromtheberlinmacularregistry AT rubsamanne correctiontotreatmentofneovascularagerelatedmaculardegenerationinsightsintodrugswitchrealworldfromtheberlinmacularregistry AT joussenantoniam correctiontotreatmentofneovascularagerelatedmaculardegenerationinsightsintodrugswitchrealworldfromtheberlinmacularregistry AT zeitzoliver correctiontotreatmentofneovascularagerelatedmaculardegenerationinsightsintodrugswitchrealworldfromtheberlinmacularregistry |